High-throughput identification of repurposable neuroactive drugs with potent anti-glioblastoma activitySohyon Lee, Berend Snijder, Miaomiao Sun et al.|Nature Medicine|2024Cited by 68
Ex vivo drug response heterogeneity reveals personalized therapeutic strategies for patients with multiple myelomaKlara Kropivšek, Berend Snijder, Paul Kachel et al.|Nature Cancer|2023Cited by 42
Targeting tumour-intrinsic neural vulnerabilities of glioblastomaSohyon Lee, Berend Snijder, Tobias Weiß et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 3